126 related articles for article (PubMed ID: 20502053)
21. Therapeutic Potential of Targeting Prokineticin Receptors in Diseases.
Vincenzi M; Kremić A; Jouve A; Lattanzi R; Miele R; Benharouga M; Alfaidy N; Migrenne-Li S; Kanthasamy AG; Porcionatto M; Ferrara N; Tetko IV; Désaubry L; Nebigil CG
Pharmacol Rev; 2023 Nov; 75(6):1167-1199. PubMed ID: 37684054
[TBL] [Abstract][Full Text] [Related]
22. A functional spectrum of PROKR2 mutations identified in isolated hypogonadotropic hypogonadism.
Wang X; Chen D; Zhao Y; Men M; Chen Z; Jiang F; Zheng R; Stamou MI; Plummer L; Balasubramanian R; Li JD
Hum Mol Genet; 2023 May; 32(10):1722-1729. PubMed ID: 36694982
[TBL] [Abstract][Full Text] [Related]
23. Prokineticin-Receptor Network: Mechanisms of Regulation.
Lattanzi R; Miele R
Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207461
[TBL] [Abstract][Full Text] [Related]
24. Oligogenic Inheritance Underlying Incomplete Penetrance of
Mkaouar R; Abdallah LCB; Naouali C; Lahbib S; Turki Z; Elouej S; Bouyacoub Y; Somai M; Mcelreavey K; Bashamboo A; Abdelhak S; Messaoud O
Front Genet; 2021; 12():665174. PubMed ID: 34539727
[TBL] [Abstract][Full Text] [Related]
25. [Molecular genetics and phenotypic features of congenital isolated hypogonadotropic hypogonadism].
Kokoreva KD; Chugunov IS; Bezlepkina OB
Probl Endokrinol (Mosk); 2021 Aug; 67(4):46-56. PubMed ID: 34533013
[TBL] [Abstract][Full Text] [Related]
26. Molecular genetic diagnostics of hypogonadotropic hypogonadism: from panel design towards result interpretation in clinical practice.
Butz H; Nyírő G; Kurucz PA; Likó I; Patócs A
Hum Genet; 2021 Jan; 140(1):113-134. PubMed ID: 32222824
[TBL] [Abstract][Full Text] [Related]
27. Sexually dimorphic distribution of Prokr2 neurons revealed by the Prokr2-Cre mouse model.
Mohsen Z; Sim H; Garcia-Galiano D; Han X; Bellefontaine N; Saunders TL; Elias CF
Brain Struct Funct; 2017 Dec; 222(9):4111-4129. PubMed ID: 28616754
[TBL] [Abstract][Full Text] [Related]
28. Prokineticin Receptor Modulators May Potentially Treat Psychiatric and Neurological Disorders.
Abdel-Magid AF
ACS Med Chem Lett; 2015 Aug; 6(8):834-5. PubMed ID: 26286844
[No Abstract] [Full Text] [Related]
29. Persistence and intergenerational transmission of differentially expressed genes in the testes of intracytoplasmic sperm injection conceived mice.
Wang LY; Wang N; Le F; Li L; Li LJ; Liu XZ; Zheng YM; Lou HY; Xu XR; Zhu XM; Zhu YM; Huang HF; Jin F
J Zhejiang Univ Sci B; 2013 May; 14(5):372-81. PubMed ID: 23645174
[TBL] [Abstract][Full Text] [Related]
30. PROK2/PROKR2 Signaling and Kallmann Syndrome.
Dodé C; Rondard P
Front Endocrinol (Lausanne); 2013; 4():19. PubMed ID: 23596439
[TBL] [Abstract][Full Text] [Related]
31. Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia.
McCabe MJ; Gaston-Massuet C; Gregory LC; Alatzoglou KS; Tziaferi V; Sbai O; Rondard P; Masumoto KH; Nagano M; Shigeyoshi Y; Pfeifer M; Hulse T; Buchanan CR; Pitteloud N; Martinez-Barbera JP; Dattani MT
J Clin Endocrinol Metab; 2013 Mar; 98(3):E547-57. PubMed ID: 23386640
[TBL] [Abstract][Full Text] [Related]
32. Evidence of the importance of the first intracellular loop of prokineticin receptor 2 in receptor function.
Abreu AP; Noel SD; Xu S; Carroll RS; Latronico AC; Kaiser UB
Mol Endocrinol; 2012 Aug; 26(8):1417-27. PubMed ID: 22745195
[TBL] [Abstract][Full Text] [Related]
33. G protein-coupled receptors: mutations and endocrine diseases.
Vassart G; Costagliola S
Nat Rev Endocrinol; 2011 Jun; 7(6):362-72. PubMed ID: 21301490
[TBL] [Abstract][Full Text] [Related]
34. The role of prokineticins in the pathogenesis of hypogonadotropic hypogonadism.
Abreu AP; Kaiser UB; Latronico AC
Neuroendocrinology; 2010; 91(4):283-90. PubMed ID: 20502053
[TBL] [Abstract][Full Text] [Related]
35. Prokineticins in central and peripheral control of human reproduction.
Traboulsi W; Brouillet S; Sergent F; Boufettal H; Samouh N; Aboussaouira T; Hoffmann P; Feige JJ; Benharouga M; Alfaidy N
Horm Mol Biol Clin Investig; 2015 Nov; 24(2):73-81. PubMed ID: 26574895
[TBL] [Abstract][Full Text] [Related]
36. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.
Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC
J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503
[TBL] [Abstract][Full Text] [Related]
37. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
Cole LW; Sidis Y; Zhang C; Quinton R; Plummer L; Pignatelli D; Hughes VA; Dwyer AA; Raivio T; Hayes FJ; Seminara SB; Huot C; Alos N; Speiser P; Takeshita A; Van Vliet G; Pearce S; Crowley WF; Zhou QY; Pitteloud N
J Clin Endocrinol Metab; 2008 Sep; 93(9):3551-9. PubMed ID: 18559922
[TBL] [Abstract][Full Text] [Related]
38. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
Pitteloud N; Zhang C; Pignatelli D; Li JD; Raivio T; Cole LW; Plummer L; Jacobson-Dickman EE; Mellon PL; Zhou QY; Crowley WF
Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17447-52. PubMed ID: 17959774
[TBL] [Abstract][Full Text] [Related]
39. The role of the prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations.
Martin C; Balasubramanian R; Dwyer AA; Au MG; Sidis Y; Kaiser UB; Seminara SB; Pitteloud N; Zhou QY; Crowley WF
Endocr Rev; 2011 Apr; 32(2):225-46. PubMed ID: 21037178
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
